Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

W. A GENO,* M. CR OWT HER , T . BA GL I N , A. FALANGA,§ H . BULLER– and G . PA LARET I ** *Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy; McMaster University, Hamilton, Canada; Department of Hematology, University of Cambridge, Cambridge, UK; §Division of Immunohematology and Transfusion Medicine, Ospedali Riuniti di Bergamo, Bergamo, Italy; –Academic Medical Center, University of Amsterdam, the Netherlands; and **Department of Angiology, University of Bologna, Italy